GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axonics Inc (MEX:AXNX) » Definitions » Price-to-Funds-From-Operations

Axonics (MEX:AXNX) Price-to-Funds-From-Operations : (As of Sep. 26, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Axonics Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Axonics Business Description

Traded in Other Exchanges
Address
26 Technology Drive, Irvine, CA, USA, 92618
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.